Carlsmed officer proposes $10.7K share sale
The notice also lists prior sales between July 7 and September 30, 2026, with share counts and amounts shown for each.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CARLSMED, Inc. (CARL) officer Jeffrey Bertolini reported a proposed sale of 747 common shares through Fidelity Brokerage Services LLC, with an aggregate market value of $10,749.33. The notice gives October 5, 2026 as the approximate sale date and identifies NASDAQ. It lists the shares as acquired from the issuer through a stock option exercise for cash on October 5, 2026, and includes prior sales dated July 7 through September 30, 2026. Daniel Tucci signed as Fidelity Brokerage Services LLC’s duly authorized representative and attorney-in-fact for Bertolini.
Key Figures
Key Terms
Rule 144 regulatory
Stock Option Exercise technical
attorney-in-fact regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.